Ascentage Pharma Group International (HKG:6855)

HKG:6855 Revenue

In the year 2024, Ascentage Pharma Group International had annual revenue of 980.65M CNY with 341.77% growth. Ascentage Pharma Group International had revenue of 156.90M in the half year ending December 31, 2024, with 37.70% growth.

• Revenue: 980.65M CNY
• Revenue Growth: +341.77%
• P/S Ratio: 24.71
• Revenue / Employee: 1.73M CNY
• Employees: 567
• Market Cap: 25.78B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	980.65M	758.67M	341.77%
Dec 31, 2023	221.98M	12.27M	5.85%
Dec 31, 2022	209.71M	181.80M	651.38%
Dec 31, 2021	27.91M	15.46M	124.18%
Dec 31, 2020	12.45M	-2.06M	-14.21%